Brachial Plexus Injury Market Research Report Information: By Type (Avulsion, Rupture, Neurapraxia, Others), By Diagnosis (Clinical Examination, Electrodiagnostic, others), By Treatment (Therapy, Surgery), By Drugs (Nsaids, Anticonvulsants, others), By Indication (Trauma, Inflammation, others) - Forecast till 2032

Table of Contents
1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of Study

2.3 Research Objective

2.4 Market Structure

3 Research Process

3.1 Primary Research

3.2 Secondary Research

3.3 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Brachial Plexus Injury Market, by Type

6.1 Introduction

6.2 Avulsion

6.3 Rupture

6.4 Neurapraxia

6.5 Axonotemesis

6.6 Neurotemesis

6.7 Neuroma

7 Global Brachial Plexus Injury Market, By Drug

7.1 Nonsteroidal anti-inflammatory drugs

7.1.1 Celecoxib

7.1.2 Naproxen

7.2 Anticonvulsants

7.2.1 Gabapentin

7.3 Tricyclic antidepressants

7.3.1 Nortriptyline

7.3.2 Doxepin

7.4 Analgesics

7.4.1 Methadone

7.4.2 Oxycodone

7.4.3 Others

8 Global Brachial Plexus Injury Market, By Diagnosis

8.1 Introduction

8.2 Clinical Examination

8.3 Electrodiagnostic Studies

8.3.1 Electromyography

8.3.2 Nerve conduction velocity

8.3.3 SNAP technology

8.3.4 Somatosensory Evoked Potential

8.4 Imaging Studies

8.4.1 CT

8.4.2 MRI

9 Global Brachial plexus injury Market, by Treatment

9.1 Introduction

9.2 Therapy

9.2.1 Physical rehabilitation therapy

9.2.2 Therapeutic taping

9.2.3 Aquatic Therapy

9.3 Surgery

9.3.1 Nerve graft

9.3.2 Nerve transfer

9.3.3 Muscle transfer

10 Global Brachial Plexus Injury Market, by Indication

10.1 Introduction

10.2 Trauma

10.3 Inflammation

10.4 Contact sports

10.5 Tumors

10.6 Radiation treatment

10.7 Others

11 Global Brachial Plexus Injury Market, by Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 U.S.

11.2.1.2 Canada

11.2.2 Latin America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 UK

11.3.1.4 Italy

11.3.1.5 Spain

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Republic Of Korea

11.4.5 Australia

11.4.6 Rest of Asia Pacific

11.5 Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Oman

11.5.4 Kuwait

11.5.5 Qatar

11.5.6 Rest of Middle East & Africa

12 Competitive Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

13 Company Profile

13.1 Novartis AG

13.1.1 Overview

13.1.2 Product/Business Segment Overview

13.1.3 Financial Overview

13.1.4 Key Development

13.2 Abbvie Inc.

13.2.1 Overview

13.2.2 Product/Business Segment Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.3 Johnson & Johnson

13.3.1 Overview

13.3.2 Product/Business Segment Overview

13.3.3 Financial Overview

13.3.4 Key Developments

13.4 GlaxoSmithKline

13.4.1 Overview

13.4.2 Product/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Developments

13.5 Eli Lilly and Company

13.5.1 Overview

13.5.2 Product/Business Segment Overview

13.5.3 Financials Updates

13.5.4 Key Developments

13.6 F. Hoffmann-La Roche AG

13.6.1 Overview

13.6.2 Product/Business Segment Overview

13.6.3 Financial Updates

13.6.4 Key Developments

13.7 Merck Sharp & Dohme Corp

13.7.1 Overview

13.7.2 Product/Business Segment Overview

13.7.3 Financial Updates

13.7.4 Key Developments

13.8 Pfizer

13.8.1 Overview

13.8.2 Product/Business Segment Overview

13.8.3 Financial Updates

13.8.4 Key Developments

13.9 Others
14 Appendix

List of Tables
TABLE 1 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 2 AVULSION FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 3 RUPTURE FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 4 NEURAPRAXIA FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 5 AXONOTEMESIS FOR CANCER BIOLOGIC THERAPY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 6 NEUROTEMESIS FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 7 NEUROMA FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 8 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY DRUGS, 2020-2027 (USD MILLION)

TABLE 9 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 10 ANTICONVULSANTS FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 11 TRICYCLIC ANTIDEPRESSANTS FOR BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 12 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY DAIGNOSIS, 2020-2027 (USD MILLION) TABLE

TABLE 13 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

TABLE 14 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 15 GLOBAL BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 16 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 17 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 18 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY DRUGS 2020-2027 (USD MILLION)

TABLE 19 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY DAIGNOSIS, 2020-2027 (USD MILLION) TABLE

TABLE 20 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

TABLE 21 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 22 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET BY REGION 2020-2027 (USD MILLION

TABLE 23 EUROPE BRACHIAL PLEXUS INJURY MARKET BY COUNTRY 2020-2027 (USD MILLION)

TABLE 24 EUROPE BRACHIAL PLEXUS INJURY MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 25 EUROPE BIOLOGICAL THERAPY MARKET, BY DRUGS 2020-2027 (USD MILLION)

TABLE 26 EUROPE BRACHIAL PLEXUS INJURY MARKET, BY DAIGNOSIS, 2020-2027 (USD MILLION) TABLE

TABLE 27 EUROPE BRACHIAL PLEXUS INJURY MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

TABLE 28 EUROPE BRACHIAL PLEXUS INJURY MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 29 EUROPE BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 30 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 31 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 32 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY DRUGS 2020-2027 (USD MILLION)

TABLE 33 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY DAIGNOSIS, 2020-2027 (USD MILLION) TABLE

TABLE 34 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

TABLE 35 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 36 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY DRUGS 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY DAIGNOSIS, 2020-2027 (USD MILLION) TABLE

TABLE 41 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY REGION 2020-2027 (USD MILLION)

List of Figures
FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET DYNAMICS FOR GLOBAL BRACHIAL PLEXUS INJURY MARKET

FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2020

FIGURE 4 BRACHIAL PLEXUS INJURY SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS

FIGURE 5 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY TYPE 2020

FIGURE 6 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY DRUGS, 2020

FIGURE 7 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY DAIGNOSIS, 2020

FIGURE 8 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY TREATMENT, 2020

FIGURE 9 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY INDICATION, 2020

FIGURE 10 GLOBAL BRACHIAL PLEXUS INJURY MARKET SHARE, BY REGION, 2020

FIGURE 11 NORTH AMERICA BRACHIAL PLEXUS INJURY MARKET SHARE, BY COUNTRY, 2020

FIGURE 12 EUROPE BRACHIAL PLEXUS INJURY MARKET SHARE, BY COUNTRY, 2020

FIGURE 13 ASIA PACIFIC BRACHIAL PLEXUS INJURY MARKET SHARE, BY COUNTRY, 2020

FIGURE 14 MIDDLE EAST & AFRICA BRACHIAL PLEXUS INJURY MARKET, BY REGION, 2020

FIGURE 15 GLOBAL BRACHIAL PLEXUS INJURY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 16 AMGEN INC.: KEY FINANCIALS

FIGURE 17 AMGEN INC.: SEGMENTAL REVENUE

FIGURE 18 AMGEN INC.: GEOGRAPHICAL REVENUE

FIGURE 19 GALXOSMITHKLINE.: KEY FINANCIALS

FIGURE 20 GALXOSMITHKLINE.: SEGMENTAL REVENUE

FIGURE 21 GALXOSMITHKLINE: GEOGRAPHICAL REVENUE

FIGURE 22 NOVARTIS AG: KEY FINANCIALS

FIGURE 23 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 24 NOVARTIS AG: GEOGRAPHICAL REVENUE

FIGURE 25 ELI LILLY AND COMPANY.: KEY FINANCIALS

FIGURE 26 ELI LILLY AND COMPANY.: SEGMENTAL REVENUE

FIGURE 27 ELI LILLY AND COMPANY: GEOGRAPHICAL REVENUE

FIGURE 28 F. HOFFMANN-LA ROCHE AG: FINANCIAL REVENUE

FIGURE 29 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE

FIGURE 30 F. HOFFMANN-LA ROCHE AG: GEOGRPAHICAL REVENUE

FIGURE 31 MERCK & CO., INC: FINANCIAL REVENUE

FIGURE 32 MERCK & CO., INC: SEGMENTAL REVENUE

FIGURE 33 MERCK & CO., INC: GEOGRPAHICAL REVENUE

FIGURE 34 PFIZER INC: FINANCIAL REVENUE

FIGURE 35 PFIZER INC: SEGMENTAL REVENUE

FIGURE 36 PFIZER INC: GEOGRPAHICAL REVENUE